Cargando…
Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression
Carcinogenesis and cancer progression, driven by mutations in oncogenes and tumor-suppressor genes, result in biological differences between normal and cancer cells in various cellular processes. Specific genes and signaling molecules involved in such cellular processes may be potential therapeutic...
Autores principales: | Watanabe, M, Abe, N, Oshikiri, Y, Stanbridge, E J, Kitagawa, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412655/ https://www.ncbi.nlm.nih.gov/pubmed/23552737 http://dx.doi.org/10.1038/oncsis.2012.21 |
Ejemplares similares
-
Identification of HeLa cell proteins that interact with Chlamydia trachomatis glycogen synthase using yeast two-hybrid assays
por: Sun, Zhenjie, et al.
Publicado: (2020) -
Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
por: Tang, Qing-Lian, et al.
Publicado: (2012) -
Characterisation of GLUT4 trafficking in HeLa cells: comparable kinetics and orthologous trafficking mechanisms to 3T3-L1 adipocytes
por: Morris, Silke, et al.
Publicado: (2020) -
Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus.
por: Su, P. F., et al.
Publicado: (1996) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)